Hypoglycemia Risk Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- ——
- ——
- ——
The Hypoglycemia Risk Score calculates predicting 12-month risk of hypoglycemic episodes in Type 2 Diabetes Mellitus (T2DM) patients for population management and targeted interventions. Key inputs include hypoglycemia admissions. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts 12-month risk of hypoglycemic episodes in Type 2 Diabetes Mellitus (T2DM) patients for population management and targeted interventions
Clinical Indication
The Hypoglycemia Risk Score is indicated for bedside clinical practice to support Predicts 12-month risk of hypoglycemic episodes in Type 2 Diabetes Mellitus (T2DM) patients for population management and targeted interventions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Risk stratification based on clinical risk factors: previous hypoglycemia admissions (highest weight), insulin/sulfonylurea use, severe kidney disease (eGFR ≤29), age ≥77 years, and frequent ED visits
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| hypoglycemia_admissions | string | Yes | Number of previous hypoglycemia-related hospital admissions |
| ed_visits_12_months | string | Yes | Number of emergency department visits in the last 12 months |
| insulin_use | string | Yes | Current insulin use |
| sulfonylurea_use | string | Yes | Current sulfonylurea use |
| severe_kidney_disease | string | Yes | Severe kidney disease (eGFR ≤29 mL/min/1.73 m²) |
| age_77_or_older | string | Yes | Age 77 years or older |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | — | <1% hypoglycemia admission risk |
| — | — | 1-5% hypoglycemia admission risk |
| — | — | >5% hypoglycemia admission risk |
Evidence-Based References (EBM)
- Karter AJ, Warton EM, Lipska KJ, et al. Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use. JAMA Intern Med. 2017;177(10):1461-1470. doi:10.1001/jamainternmed.2017.3844DOI: 10.1001/jamainternmed.2017.3844
- Lipska KJ, Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013;36(11):3535-42. doi: 10.2337/dc13-0610DOI: 10.2337/dc13-0610